Medical information  
 
 Terms Glossary
 First Aid
 Diet Information
 Preventive Medicine
 Immunization Schedules
 Biological Warfare Effects & Treatment
 Men's health
 Infertility
 Atlas of skin diseases
 Drug encyclopedia
 Atlas of human anatomy
 Alternative medicine
 Baby's developmental milestones
 Medical laboratory tests
 Smoking and health effect
 Advice for travelers
 Hearth attack: risk chart
 Diabetes: risk chart
 Cancer: risk chart
 Alcoholism and treatment
 Topic of the Week
 Medical Topic
 Latest News
 News Archive
 
  » Medical laboratory tests  »  Normal Laboratory Values In Tabular Form
Determination Reference Range Minimal
mL
Required
Note
Conventional SI
Acetoacetate plus acetone Negative   1-B  
Aldolase 1.3-8.2 u./L 2-137 nmol-
sec-1/L
2-S Use unhemolyzed serum
Ammonia 12-55 µ mol/L 12-55 µ mol/L 2-B Collect in heparinized tube; deliver immediately packed in ice
Amylase 53-123 u./L 884-2050 nmol-sec-1/L 1-S  
Ascorbic acid 0.4-1.5 mg/dL 23-85 m mol/L 7-B Collect in heparinized tube before any food is given
Bilirubin Direct: up to 0.4 mg/dL
Total: up to 1.0 mg/dL
Up to 7 m mol/L
Up to 17 m mol/L
1-S  
Blood volume 8.5-9.0% of body wt in kg 80-85 mL/kg    
Calcium 8.5-10.5 mg/dL (slightly higher in children) 2.1-2.6 mmol/L 1-S  
Carbamazepine 4.0-12.0 m g/mL 17-51 m mol/L    
Carbon dioxide content 24-30 mEq/L 24-30 mmol/L 1-S Fill tube to top
Carbon monoxide Less than 5% of total hemoglobin   3-B Fill tube to top
Carotenoids 0.8-4.0 m g/mL 1.5-7.4 m mol/L 3-S Vitamin A may be done on same specimen
Ceruloplasmin 23-43 mg/dL 1.5-2.9 m mol/L 2-S  
Chloramphenicol 10-20 m g/mL 31-62 m mol/L 0.2-S  
Chloride 100-108 mmol/L 100-108 mmol/L 1-S  
Copper Total: 70-150 m g/dL 11-24 m mol/L 1-S  
Creatine kinase
(CK)
Female: 10-79 u./L
Male: 17-148 u./L
167-1317 nmol-sec-1/L
283-2467 nmol-sec-1/L
1-S  
CK isoenzymes 5% MB or less   0.2-S  
Creatinine 0.6-1.5 mg/dL 53-133 m mol/L 1-S  
Ethanol 0 mg/dL 0 mmol/L 2-B Collect in oxalate and refrigerate
Glucose Fasting: 70-110 mg/dL 3.9-5.6 mmol/L 1-P Collect with oxalate-fluoride mixture
Iron 50-150 m g/dL (higher in males) 9.0-26.9 m mol/L 1-S  
Iron-binding capacity 250-410 m g/dL 44.8-73.4 m mol/L 1-S  
Lactic acid 0.5-2.2 mmol/L 0.5-2.2 mmol/L 2-B Collect with oxalate-fluoride mixture; deliver immediately packed in ice
Lactic dehydrogenase 45-90 u./L 750-1500 nmol-sec-1/L 1-S Unsuitable if hemolyzed
Lead 50 m g/dL or less Up to 2.4 m mol/L 2-B Collect with oxalate-fluoride mixture
Lipase 4-24 u./dL 667-4001 nmol-sec-1/L 1-S  
Lipids
Cholesterol
Triglycerides
120-220 mg/dL
40-150 mg/dL
3.10-5.69 mmol/L
0.4-1.5 gm/L
1-S
1-S
Fasting
Fasting
Lipoprotein electrophoresis (LEP)     2-S Fasting; do not freeze serum
Lithium 0.5-1.5 mEq/L 0.5-1.5 mmol/L 1-S  
Magnesium 1.5-2.0 mEq/L 0.8-1.3 mmol/L 1-S  
5--Nucleotidase 1-11 u./L 17-183 nmol-sec-1/L 1-S  
Osmolality 280-296 m0sm/kg water 280-296 mmol/kg 1-S  
Oxygen saturation (arterial) 96-100% 0.96-1.001 3-B Deliver in sealed heparinized syringe packed in ice
Pco2 35-45 mm Hg 4.7-6.0 kPa 2-B Collect and deliver in sealed heparinized syringe
pH 7.35-7-45 Same 2-B Collect without stasis in sealed heparinized syringe; deliver packed in ice
Pco2 75-100 mm Hg (dependent on age) while breathing room ait
Above 500 mm Hg while on 100% O2
10.0-13.3 kPa 2-B  
Phenobarbital 15-50 m g/mL 65-215 m mol/L 1-S  
Phenylalanine 0-2 mg/dL 0-120 m mol/L 0.4-S  
Phenytoin Therapeutic level: 5-20 m g/mL 19.8-79-5 m mol/L 1-S  
Phosphatase (acid)
Prostatic
0-0.8 u./L 0-13.3 nmol-sec-1/L 1-S Must always be drawn just before analysis or stored as frozen serum; avoid hemolysis
Phosphatase (alkaline) 13-39 u./L; infants and adolescents up to 104 u./L 217-650 nmol-sec-1/L; up to 1.26 m mol-sec-1/L 1-S  


NORMAL LABORATORY VALUES IN THE MASSACHUSETTS GENERAL HOSPITAL (Cont-d)
BLOOD, PLAZMA, OR SERUM VALUES (Cont-d)
Determination Reference Range Minimal
mL
Required
Note
Conventional SI
Phosphorus (inorganic) 3.0-4.5 mg/dL (infants in 1st year up to 6.0 mg/dL) 1.0-1.5 mmol/L 1-S  
Potassium 3.5-5.0 mEq/L 3.5-5.0 mmol/L 1-S Serum must be separated promptly from cells
Primidone Therapeutic level: 4-12 m g/mL 18-55 m mol/L 1-S  
Procainamide 4-10 m g/mL 17-42 m mol/L 1-S  
Protein: Total
Albumin
Globulin
Electrophoresis
Albumin
Globulin:
a 1
a 2
b
g
6.0-8.4 gm/dL
3.5-5.0 gm/dL
2.3-3.5 gm/dL
% of total reotein
52-68
 
4.2-7.2
6.8-12
9.3-15
13-23
60-84 gm/L
35-50 gm/L
23-35 gm/L
1-S
1-S
1-S
Globulin equals total protein minus albumin Quantitation by densitometry
Pyruvic acid 0-0.11 mEq/L 0-0.11 mmol/L 2-B Collect with oxalate-fluoride; deliver immediately packed in ice
Quinidine 1.2-4.0 m g/mL 3.7-12.3 m mol/L 1-S  
Salicylate 100-200 mg/L 724-1448 m mol/L 2-P  
Sodium 135-145 mEq/L 135-145 mmol/L 1-S  
Sulfonamide 5-15 mg/dL   2-P  
Transaminase
(AST or SGOT)
(ALT or SGPT)
7-27 u./L
1-21 u./L
117-450 nmol-sec-1/L
17-350 nmol-sec-1/L
1-S 
Urea nitrogen (BUN) 8-25 mg/dL 2.9-8.9 mmol/L 1-S  
Uric acid 3.0-7.0 mg/dL 0.18-0.42 mmol/L 1-S  
Vitamin A 0.15-0.6 m g/mL 0.5-2.1 m mol/L 3-S  


URINE VALUES
Determination Reference Range Minimal
Quantity
Required
Note
Conventional SI
Acetone plus acetoacetate (quantitative) 0 0 mg/L 2 mL  
Amylase 0-375 u./L 0-6251 nmol-sec-1/L    
Calcium 300 mg/day or less 7.5 mmol/day or less 24-h specimen Collect in special bottle with 10 mL of concentrated HCI
Catecholamines
Epinephrine
Norepinephrine
< 20 m g/day
< 100 m g/day
< 109 nmol/day
< 590 nmol/day
24-h specimen Collect with 10mL of concentrated HCI (pH should be 2.0-3.0)
Chorionic gonadotropin 0 0 arb. u. First morning voiding  
Cooper 0-100 m g/day 0-1.6 m mol/day 24-h specimen  
Coproporphyrin 50-250 m g/day
Children < 80 lb (36 kg): 0-75 m g/day
80-380 nmol/day
0-115 nmol/day
24-h specimen Collect with 5 gm of sodium carbonate
Creatine < 100 mg/day or < 6% of creatinine. In pregnancy, up to 12%. In children < 1 yr, may equal creatinine; in older children, up to 30% of creatinine < 0.75 mmol/day 24-h specimen Order serum creatinine also
Creatinine 15-25 mg/kg/day 0.13-0.22 mmol-kg-1/day 24-h specimen  
Cystine or cysteine 0 0 10 mL Qualitative
Hemoglobin and myoglobin 0   Freshly voided sample Chemical examination with benzidine
5-Hydroxyindoleacetic acid 2-9 mg/day (women lower than men) 10-45 m mol/day 24-h specimen Collect in special bottle with 10 mL of concentrated HCI
Lead 0.08 m g/mL or 120 m g or less/day 0.39 m mol/L or less 24-h specimen  
Phosphorus (inorganic) Varies with intake; average 1 gm/day 32 mmol/day 24-h specimen Collect in special bottle with 10 mL of concentrated HCI
Porphobilinogen 0 0 10 mL Se freshly voided urine
Protein:
Quantitative
< 165 mg/24 h < 0.16 gm/day 24-h specimen  
Steroids:
17-Ketosteroids

Age
10
20
30
50
70
mg/day
Male
1-4
6-21
8-26
5-18
2-10

Female
1-4
4-16
4-14
3-9
1-7

Male  
3-14
21-73
28-90
17-62
7-35

m mol/day

Female
3-14
14-56
14-49
10-31
3-24
24-h specimen Not valid if patient isreceiving meprobamate
17-Hydroxy-steroids 3-8 mg/day (women lower than men) 8-22 m mol/day as tetrahydrocortisol 24-h specimen Keep cold; chlorpromazine and related drugs interfere with assay
Sugar:
Quantitative glucose
0 0 mmol/L 24-h or other timed specimen  
Urobilinogen Up to 1.0 Ehrlich u. To 1.0 arb. u. 2-h specimen (1-3 PM)  
Uroporphyrin 0-30 m g/day < 36 nmol/day See Coproporphyrin  
Vanilyimadelic acid (VMA) Up to 9 mg/24 h Up to 45 m mol/day 24-h specimen Collect as for catecholamines


SPECIAL ENDOCRINE TESTS
Determination Reference Range Minimal
mL
Required
Note
Conventional SI
Steroids hormones
Aldosterone
 
 
 
 
 
Cortisol
Excretion: 5-19 m g/24 h
Supine: 48± 29 ph/mL
Upright: (2 h) 65± 23 pg/ml
Supine: 107± 45 pg/ml
Upright: (2 h) 239± 123 pg/ml
Supine: 175± 75 pg/ml
Upright: (2 h) 532± 228 pg/ml
8 AM: 5-25 m g/dL
8 PM:< 10 m g/dL
4-h ACTH test: 30-45 m g/dL
Overnight suppression test: < 5 m g/dL
Excretion: 20-70 m g/24 h
14-53 mmol/day
133± 80 pmol/L
180± 64 pmol/L
279± 125 pmol/L
663± 341 pmol/L
485± 208 pmol/L
1476± 632 pmol/L
0.14-0.69 m mol/L
0-0.28 m mol/L
0.83-1.24 m mol/L
< 0.14 nmol/L
55-193 nmol/day
5/day
3-S,P
 
 
 
 
1-P
1-P
1-P
1-P
2-day
Keep specimen cold
Fasting, at rest, 210-mEq Na diet
Upright, 2h, 210-mEq Na diet
Fasting, at rest, 110-mEq Na diet
Upright, 2h, 110-mEq Na diet
Fasting, at rest, 10-mEq Na diet
Upright, 2h, 10-mEq Na diet
Fasting
At rest
20 u. ACTH IV/4 h
8 AM sample after 0.5 mg dexamethasone at midnight
Keep specimen cold
Dehydroepiandrosterone (DHEA)
Dehydroepiandrosterone sulfate
(DHEA)
11-Deoxycortisol
 
Estradiol
 
 
Progesterone
 
 
Testosterone
 
Unbound
testosterone
Male: 0.5-5.5 ng/mL
Female: 1.4-8.0 ng/mL
0.3-4.5 ng/mL
Male: 151-466 m g/mL
Female: 84-433 m g/mL
1.7-177 m g/mL
Responsive: > 7.5 m g/dL

 
Male: < 50 pg/mL
Female: 23-361 pg/mL
< 30 pg/mL
< 20 pg/mL
Male: < 1.0 ng/mL
Female: 0.2-0.6 ng/mL
0.3-3.5 ng/mL
6.5-32.2 ng/mL
Adult male: 300-1100 ng/dL
Adolescent male: > 100 ng/dL
Female: 25-90 ng/dL
Adult male: 3.06-24 ng/dL
Adult female: 0.09-1.28 ng/dL
1.7-19 nmol/L
4.9-28 nmol/L
1.0-15.6 nmol/L
3.9-11.4 m mol/L
2.2-11.1 m mol/L
0.04-4.5 m mol/L
> 0.22 m mol/L

 
< 184 pmol/L
84-1325 pmol/L
< 110 pmol/L
< 73 pmol/L
< 3.2 nmol/L
0.6-1.9 nmol/L
0.95-11 nmol/L
21-108 nmol/L
10.4-38.1 nmol/L
> 3.5 nmol/L
0.87-3.12 nmol/L
106-832 pmol/L
3.1-44.4 pmol/L
2-S,P

 
2-S,P

 
1-P

 
5-S,P

 
 
5-S,P
 
 
1-P

 
2- P
Adult
Postmenopausal
Adult
Postmenopausal
8 AM sample preceded by metyrapone 4.5 gm orally/24 h or by single 2.5-gm dose orally at midnight
Adult
Postmenopausal
Prepubertal
Follicular phase
Midcycle peak
Postovulatory phase
AM sample
 
AM sample
Polypeptide hormones ACTH
Calcitonin
 
Follicle-stimulating hormone
 
Growth hormone
 
 
 
 
Insulin
15-70 pg/mL
Male: 0-14 pg/mL
Female: 0-28 pg/mL
> 100 pg/mL in medullary carcinoma
Male: 3-18 mu./mL
Female: 4.6-22.4 mu./mL
13-41 mu./mL
30-170 mu./mL
< 5 ng/mL
Children: > 10 ng/mL
Male: < 5 ng/mL
Female:Up to 30 ng/mL
Male: < 5 ng/mL
Female: < 5 ng/mL
6-26 m u./mL
< 20 m u./mL
Up to 150 m u./mL
3.3-15.4 pmol/L
0-4.1 pmol/L
0-8.2 pmol/L
> 29-3 pmol/L
3-18 arb. u.
4.6-22.4 arb. u.
13-41 arb. u.
30-170 arb. u.
< 233 pmol/L
> 465 pmol/L
< 233 pmol/L
0-1395 pmol/L
< 233 pmol/L
< 233 pmol/L
43-187 pmol/L
< 144 pmol/L
0-1078 pmol/L
5-P

5-S

 
5-S,P

 
 
1-S

 
 
 
 
1-S
Place specimen in ice and send promptly to laboratory. Use EDTA tube only
Test done only on known or suspected cases of medullary carcinoma of the thyroid
Same sample may be used for LH
Pre- or postovulatory
Midcycle peak
Postmenopausal
Fasting, at rest
After exercise
 
After glucose load
Fasting
During hypoglycemia
After glucose load
Polypeptide hormones
(cont-d)
Luteinzing hormone
 
 
Parathyroid hormone
Proclactin
Renin activity
 
 
 
Somatomedin C
(Sm-C, ICF-1)
 
Male: 3-18 mu./mL
Female: 2.4-34.5 mu./mL
43-187 mu./mL
30-150 mu./mL
< 25 pg/mL
2-15 ng/mI
Supine: 1.1± 0.8 ng/mL/h
Upright: 1.9± 1.7 ng/mL/h
Supine: 2.7± 1.8 ng/mL/h
Upright: 6.6± 2.5 ng/mL/h
Diuretics: 10.0± 3.7 ng/mL/h
0.08-2.8 u./mL
0.9-5.9 u./mL
0.34-1.9 u./mL
0.45-2.2 u./mL
 
3-18 abr.u.
2.4-34.5 abr.u.
43-187 abr.u.
30-150 abr.u.
< 2.94 pmol/L
0.08-6.0 nmol/Lh
0.9± 0.6 (nmol/L)h
1.5± 1.3 (nmol/L)h
2.1± 1.4 (nmol/L)h
5.1± 1.9 (nmol/L)h
7.7± 2.9 (nmol/L)h
0.08-2.8 abr.u.
0.9-5.9 abr.u.
0.34-1.9 abr.u.
0.45-22 abr.u.
 
5-S,P

 
 
5-P

2-S
4-P

 
 
 
2-P
 
Pre- or postovulatory
Midcycle peak
Postmenopausal
Keep blood on ice, or plasma must be frozen if it is to be sent any distance; AM sample
EDTA tubes, on ice; normal diet
 
Low Na diet
Low Na diet
Prepubertal
During puberty
Adult males
Adult females
Tryroid hormones
Ttyroid- stimulating hormone (TSH)
Thyroxine-binding globulin
capacity
Total
triiodothyronine by radiommuno-assay (T3)
Reverse diiodothyronine (rT3)
Total thyroxine by radioimmunoassay (T4)
T3 resin uptake
Free thyroxine index (FT4I)
0.5-5.0 mu/mL

 
15-25 m g T4/dL

 
75-195 ng/dL

 
 
13-53 ng/mI

 
4-12 m g/dL

 
25-35%
1-4
0.5-5.0 mu./L

 
193-322 nmol/L

 
1.16-3.00 nmol/L

 
 
0.2-0.8 nmol/L

 
52-154 nmol/L

 
0.25-0.35
2-S

 
2-S

 
2-S

 
 
2-S
 
1-S

 
2-S
2-S
EDTA plasma

HEMATOLOGIC VALUES

Determination Reference Range Minimal
mL
Required
Note
Conventional SI
Coagulation factors Factor I
(fibrinogen)
Factor II
(prothrombin)
Factor V
(accelerator globulin)
Factor VII-X
(proconvertin-Stuart)
Factor X (Stuart factor)
Factor VIII
(antihemophilic globulin)
Factor IX (plasma thromboplastic cafactor)
Factor XI (plasma thromboplastic antecedent)
Factor XII
(Hageman factor)
0.15-0.35gm/dl

60-140%

60-140%

 
70-130%

 
70-130%

50-200%

 
60-140%

 
60-140%

 
60-140%
4.0-10.0 m mol/L
0.60-1.40
0.60-1.40
 
0.70-1.30
 
0.70-1.30
0.50-2.0
 
0.60-1.40
 
0.60-1.40
 
0.60-1.40
4.5-P

4.5-P

4.5-P

 
4.5-P

 
4.5-P

4.5-P

 
4.5-P

 
4.5-P

 
4.5-P
Collect in vacuum tube containing sodium citrate
Collect in plastic tubes with 3.8% sodium citrate
Collect as for factor II
 
Collect as for factor II
 
Collect as for factor II
Collect as for factor II
 
Collect as for factor II
 
Collect as for factor II
 
Collect as for factor II
Coagulation screening tests
Bleeding time
Prothrombin time
Partial thromboplastin time (activated)
Whole-blood clot lysis
 
3-9.5 min
< 2-sec deviation from control

25-38 sec

 
No clot lysis in 24 h
 
180-570 sec
< 2-sec deviation from control

25-38 sec

 
0/day
 
 
4.5-P

4.5-P

 
2.0 whole blood
 
 
Collect in vacuum tube containing 3.8% sodium citrate
Collect in vacuum tube containing 3.8% sodium citrate
Collect in sterile tube and incubate at 37oC
Fibrinolytic studies
Euglobin lysis
Fibrinogen split products
Thrombin time
No lysis in 2 h
Negative reaction at > 1:4 dilution

Control ± 5 sec
0 (in 2 h)
0 (at > 1:4 dilution)

Control ± 5 sec
4.5-P
4.5-S

4.5-P
Collect as for factor II
Collect in special tube containing thrombin and aminocaproic acid
Collect as for factor II
"Complete" blood count
Hematocrit
Hemoglobin
Leukocyte count
Erythrocyte count
MCV
MCH
MCHC
 
Male: 45-52%
Female: 37-48%
Male: 13-18 gm/dL
Female: 12-16 gm/dL
4300-10,800/m L
4.2-5-9 million/m L
86-98 m m3/cell
27-32 pg
32-36%
 
0.45-0.52
0.37-0.48
8.1-11.2 mmol/L
7.4-9.9 mmol/L
4.3-10.8 x 109/L
4.2-5.9 x 1012/L
86-98 fl (femtoliter)
1.7-2.0 pg/cell
0.32-0.36
 
1-B
 
Use EDTA as anticoagulant; the 7 listed tests are performed automatically on the Ortho ELT 800, which directly determines cell counts, Hb (as the cyanmethemoglobin derivative), and MCV, and computes Hct, MCH, and MCHC.
MCV = mean corpuscular volume
MCH = mean corpuscular hemoglobin
MCHC = mean corpuscular hemoglobin concentration
ESR Male: 1-13 mm/h
Female: 1-20 mm/h
1-13 mm/h
1-20 mm/h
5-B Use EDTA as anticoagulant
Erythrocyte enzymes
Glucose-6-phosphate dehydrogenaze
Pyruvate kinase
Ferritin (serum)
Iron deficiency
Iron excess
Folic acid
Normal
Borderline
Haptoglobin
 
5-15 u./gm Hb

 
13-17 u./gm Hb

0-12 ng/mL (borderline: 13-20)
> 400 ng/L

> 3.3 ng/mL
2.5-3.2 ng/mL
40-336 mg/dL
 
5-15 u./gm

 
13-17 u./gm

0-4.8 nmol/L (borderline: 5.2-8)
> 160 nmol/L

> 7.3 nmol/L
5.75-7.39 nmol/L
0.4-336 gm/L
 
9-B

 
8-B

 
 
 
1-S
1-S
1-S
 
Use special anticoagulant (ACD solution)
 
Use special anticoagulant (ACD solution)
 
Hemoglobin studies
Electrophoresis for abnormal Hb
Electrophoresis for A2 Hb
Fetal Hb
Met- and sulf-Hb
Serum Hb
Thermolabile Hb
Lupus anticoagulant
 
 
1.5-3.5% (borderline: 0.3-3.5%)

< 2%
0
2-3 mg/dL
0
0
 
 
0.015-0.035 (borderline: 0.03-0.035)

< 0.02
0
1.2-1.9 m mol/L
0
0
5-B

5-B

5-B
5-B
2-B
1-B
4.5-P
Collect with anticoagulant
Use oxalate as anticoagulant
Collect with anticoagulant
Use heparin as anticoagulant.
Any anticoagulant.
Collect as for factor II
LE (lupus erythematosus cell preparation
Hargraves method
Barnes method)
 
 
0
0
 
 
0
0
 
 
5-B
5-B
 
 
Use heparin as anticoagulant.
Use defibrinated blood
Leukocyte alkaline phosphatase:
Qualitative method
 
Males: 33-188 u.
Females (off contraceptive pill): 30-160 u.
   
Smear-B
 
Muramidase (lysozyme) Serum: 3-7 m g/mL
Urine: 0-2 m g/mL
3-7 mg/mL
0-2 mg/mL
1-S
1-U
 
Osmotic fragility of erythrocytes Increased if hemolysis occurs in > 0.5%
NaCl; decreased if hemolysis is incomplete in 0.3% NaCl
  5-B Use heparin as anticoagulant.
Peroxide hemolysis < 10% < 0.10 6-B Use EDTA as anticoagulant.
Platelet count 150,000-350,000/m L 150-350 x 109/L 0.5-B Use EDTA as anticoagulant. Counts are performed on Clay Adams Ultraflow. Low counts are confirmed by hand counting
Platelet function tests
Clot retraction
Platelet aggregation
Platelet factor 3
Reticulocyte count
Vitamin B12
 
50-100%/2h
Full response to ADP,
epinephrine, and collagen
33-57 sec
0.5-2.5% red cells
205-876 pg/mL (borderline: 140-204)
]

0.50-1.00/2h
1.0

33-57 sec
0.005-0.025
150-674 pmpl/L (borderline: 102.6-149)
 
4.5-P
18-P

4.5-P
0.1-B
12-S
 
Collect as for factor II
Collect as for factor II
Collect as for factor II


NORMAL LABORATORY VALUES IN THE MASSACHUSETTS GENERAL HOSPITAL (Cont-d)
CEREBROSPINAL FLUID VALUES
Determination Reference Range Minimal
mL
Required
Note
Conventional SI
Bilirubin 0 0 µ mol/L 2  
Cell count 0-5 mononuclear cells   0.5  
Chloride 120-130 mEq/L 120-130 mmol/L 0.5 20 mEq/L higher than serum chloride
Colloidal gold 0000000000-0001222111 Same 0.1  
Albumin Mean: 29.5 mg/dL
± 2 SD: 11-48 mg/dL
0.295 gm/L
0.11-0.48
2.5  
IgG Mean: 4.3 mg/dL
± 2 SD: 0-8.6 mg/dL
0.043 gm/L
0-0.086
   
Glucose 50-75 mg/dL 2.8-4.2 mmol/L 0.5 30-50% less than blood glucose
Pressure 70-180 mm of water 70-180 arb. u.    
Protein:
Lumbar
Cisternal
Ventricular
15-45 mg/dL
15-25 mg/dL
5-15 mg/dL

0.15-0.45
0.15-0.25 gm/L
0.05-0.15 gm/L

1
1
1
 


MISCELLANEOUS VALUES

Determination Reference Range Minimal
mL
Required
Note
Conventional SI
Carcinoembryonic antigen (CEA) 0-2.5 ng/mL 0-2.5 m g/L 20-P Must be sent on ice
Chylous fluid 0-5 mononuclear cells     Use fresh specimen
Digitoxin 120-130 mEq/L 11.8-32.8 nmol/L 1-S Medication with digitoxin or digitalis
Digoxin 0000000000-0001222111 1.15-2.56 nmol/L 1-S  
Gastric analysis Basal:
Females 2.0±1.8 mEq/h
Males: 3.0± 2.0 mEq/h
Maximal: (after histalog or gastrin)
Females 16±5 mEq/h
Males: 23±5 mEq/h
0.6± 0.5 m mol/sec
0.8± 0.6 m mol/sec

4.4± 1.4 m mol/sec
6.4± 1.4 m mol/sec
   
Immunologic tests
a -Fetoglobulin
a 1-Antitryspin
Antinuclear antibodies
Anti-DNA antibodies
Bence-Jones protein
Complement, total hemolytic
C3
C4
Rheumatoid factor
Immunoglobulins
IgG
IgA
IgM
Visconsity
Undetectable in normal adults
85-213 mg/dL
Negavite at a 1:8 dilution of serum

Negavite at a 1:10 dilution of serum

Abnormal if present
150-250 u./mL

Range: 83-177 mg/dL
Range: 15-45 mg/dL
< 60 IU/mL

639-1349 mg/dL
70-312 mg/dL
86-352 mg/dL
1.4-1.8 relative viscosity units
 
0.85-2.13 gm/L

 
 
 
 
 
 
0.83-1.77 gm/L
0.15-0.45 gm/L

 
6.39-13.49 gm/L
0.7-3.12 gm/L
0.86-3.52 gm/L
2-S
10-B
2-S

2-S

50-u
10-B

2-S
2-S
10 mL clotted blood
2-S
2-S
2-S
10-B
 
 
 
Send to laboratory promptly
 
 
 
Must be sent on ice
 
 
Fasting sample preferred
 
 
 
Expressed as the relative viscosity of serum compared with water
Iontophoresis Children: 0-40 mEq Na/L
Adults: 0-60 mEq Na/L
0-40 mmol/L
0-60 mmol/L
   
Stool fat < 5 gm in 24 h or < 4% of measured fat intake in 3-day period < 5 gm/day 24 h or 3-day specimen  
Stool nitrogen < 2 gm/day or 10% of urinary nitrogen < 2 gm/day 24 h or 3-day specimen  
Synovial fluid
Glucose
Not < 20 mg/dL lower than simultaneously drawn blood sugar See blood glucose 1 mL of fresh fluid Collect with oxalate-fluoride mixture
D-Xylose absorption 5-8 gm/5 h in urine
(40 mg/dL in blood after 2 h of ingestion of 25 gm D-xylose)
33-53 mmol
(2.7 mmol/L)
5-U
5-B
Administer 25 gm of D-xylose orally

* Blood lead levels much lower than this are of concern in children. For discussion, see Ch. 192.
SI = Système International d-Unités; P = plasma; B = blood; S = serum; U = urine.
Modified from The New England Journal of Medicine 314(1): 39-49, January 2, 1986, and 315(25): 1606, December 18, 1986; used with permission of The Massachusetts General Hospital and The New England Journal of Medicine.